Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation

Clinical trial NCT01564563 · TERMINATED

Trial details

NCT number: NCT01564563
Sponsor: Novo Nordisk A/S
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Bleeding During/Following Surgery

Start date: 2002-06-28
Primary completion: 2003-10-27
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.